These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. Freeman E; Rickels K; Sondheimer SJ; Polansky M JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047 [TBL] [Abstract][Full Text] [Related]
5. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. Sampson GA Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093 [TBL] [Abstract][Full Text] [Related]
6. Progesterone and the premenstrual syndrome: a double blind crossover trial. Dennerstein L; Spencer-Gardner C; Gotts G; Brown JB; Smith MA; Burrows GD Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1617-21. PubMed ID: 3924191 [TBL] [Abstract][Full Text] [Related]
7. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group. Magill PJ Br J Gen Pract; 1995 Nov; 45(400):589-93. PubMed ID: 8554838 [TBL] [Abstract][Full Text] [Related]
11. Course of premenstrual syndrome symptom severity after treatment. Freeman EW; Rickels K; Sondheimer SJ Am J Psychiatry; 1992 Apr; 149(4):531-3. PubMed ID: 1554040 [TBL] [Abstract][Full Text] [Related]
12. Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone. Dennerstein L; Morse C; Gotts G; Brown J; Smith M; Oats J; Burrows G J Affect Disord; 1986; 11(3):199-205. PubMed ID: 2951407 [TBL] [Abstract][Full Text] [Related]
13. Bromocriptine and premenstrual tension: a clinical and hormonal study. Andersch B; Hahn L Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512 [TBL] [Abstract][Full Text] [Related]
15. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial. Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858 [TBL] [Abstract][Full Text] [Related]
16. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. Vanselow W; Dennerstein L; Greenwood KM; de Lignieres B J Psychosom Obstet Gynaecol; 1996 Mar; 17(1):29-38. PubMed ID: 8860884 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092 [TBL] [Abstract][Full Text] [Related]
18. Trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Dalton K Am J Obstet Gynecol; 1987 Jun; 156(6):1555-6. PubMed ID: 3296762 [No Abstract] [Full Text] [Related]
19. Serum progesterone levels following vaginal administration of progesterone during the luteal phase. Myers ER; Sondheimer SJ; Freeman EW; Strauss JF; Rickels K Fertil Steril; 1987 Jan; 47(1):71-5. PubMed ID: 3792576 [TBL] [Abstract][Full Text] [Related]
20. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Smith S; Rinehart JS; Ruddock VE; Schiff I Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]